Arizona § 36-2452 Distribution and sale of laetrile; labeling requirements

Arizona Statutes

§ 36-2452 — Distribution and sale of laetrile; labeling requirements

Arizona § 36-2452

Title 36Arizona Revised Statutes

Ch. 26NUTRITIONAL SUPPLEMENTS

Art. 1General Provisions

This text of Arizona § 36-2452 (Distribution and sale of laetrile; labeling requirements) is published on Counsel Stack Legal Research, covering Arizona primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Ariz. Rev. Stat. Ann. § 36-2452 (2026).

Text

A.Laetrile may be distributed or sold by any person within this state and no special license or prescription shall be required for the sale or distribution of this nutritional supplement.

B.The label or other device affixed to a container containing laetrile shall:

1.Clearly identify the nutritional supplement contained therein as laetrile or amygdalin and, at the option of the manufacturer, vitamin B-17.

2.Include a statement that the nutritional supplement contained therein has not been approved as a treatment or cure for cancer by the food and drug administration of the United States department of health, education and welfare.

Free access — add to your briefcase to read the full text and ask questions with AI

A. Laetrile may be distributed or sold by any person within this state and no special license or prescription shall be required for the sale or distribution of this nutritional supplement.

B. The label or other device affixed to a container containing laetrile shall:

1. Clearly identify the nutritional supplement contained therein as laetrile or amygdalin and, at the option of the manufacturer, vitamin B-17.

2. Include a statement that the nutritional supplement contained therein has not been approved as a treatment or cure for cancer by the food and drug administration of the United States department of health, education and welfare.